- Home
- TKNO vs NMAI Comparison
TKNO vs NMAI Comparison
Compare TKNO & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- NMAI
- Stock Information
- Founded
- TKNO 1996
- NMAI 2021
- Country
- TKNO United States
- NMAI United States
- Employees
- TKNO N/A
- NMAI N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- NMAI Investment Managers
- Sector
- TKNO Health Care
- NMAI Finance
- Exchange
- TKNO Nasdaq
- NMAI Nasdaq
- Market Cap
- TKNO 356.4M
- NMAI 382.1M
- IPO Year
- TKNO 2021
- NMAI N/A
- Fundamental
- Price
- TKNO $5.75
- NMAI $12.54
- Analyst Decision
- TKNO Buy
- NMAI
- Analyst Count
- TKNO 1
- NMAI 0
- Target Price
- TKNO $5.00
- NMAI N/A
- AVG Volume (30 Days)
- TKNO 421.2K
- NMAI 74.8K
- Earning Date
- TKNO 05-08-2025
- NMAI 01-01-0001
- Dividend Yield
- TKNO N/A
- NMAI 13.14%
- EPS Growth
- TKNO N/A
- NMAI N/A
- EPS
- TKNO N/A
- NMAI 0.64
- Revenue
- TKNO $38,250,000.00
- NMAI N/A
- Revenue This Year
- TKNO $8.73
- NMAI N/A
- Revenue Next Year
- TKNO $16.53
- NMAI N/A
- P/E Ratio
- TKNO N/A
- NMAI $19.03
- Revenue Growth
- TKNO 3.79
- NMAI N/A
- 52 Week Low
- TKNO $1.16
- NMAI $10.60
- 52 Week High
- TKNO $10.37
- NMAI $12.55
- Technical
- Relative Strength Index (RSI)
- TKNO 40.50
- NMAI 68.35
- Support Level
- TKNO $5.59
- NMAI $12.19
- Resistance Level
- TKNO $6.01
- NMAI $12.37
- Average True Range (ATR)
- TKNO 0.37
- NMAI 0.12
- MACD
- TKNO -0.10
- NMAI 0.01
- Stochastic Oscillator
- TKNO 11.39
- NMAI 84.09
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.